Cytek Biosciences (CTKB) Non Operating Interest Expenses (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Non Operating Interest Expenses came in at $281000.0 in Q2 2026, down 32.13% on a YoY basis from $414000.0 in Q2 2025, and up 7.25% quarter-over-quarter from $262000.0 in Q1 2026.
Powered by 
Analysis
Cytek Biosciences (CTKB) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has reported Non Operating Interest Expenses for 7 consecutive years, with $281000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 32.13% year-over-year to $281000.0; the trailing twelve-month figure through Jun 2026 stood at $312000.0 (up 106.11% YoY), and the FY2025 full-year result was $474000.0, up 109.05% from the prior year.
- Non Operating Interest Expenses climbed to $281000.0 in Q2 2026 per CTKB's latest filing, from $262000.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $687000.0 in Q4 2022 and bottomed at -$5.9 million in Q4 2024.
- Historically, Non Operating Interest Expenses has averaged $23444.4 across 5 years, with a median of $411500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses plunged 1605.84% in 2024, then surged 315.13% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $687000.0 in 2022, then slumped by 42.65% to $394000.0 in 2023, then slumped by 1605.84% to -$5.9 million in 2024, then jumped by 87.78% to -$725000.0 in 2025, then jumped by 138.76% to $281000.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $281000.0, $262000.0, and -$725000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.71 Bn | 220.64 Bn | 8.34 Bn | 401.00 Mn |
| 2 | Danaher | 144.49 Bn | 140.14 Bn | 3.61 Bn | 107.00 Mn |
| 3 | Agilent Technologies | 40.95 Bn | 39.19 Bn | 1.04 Bn | 29.00 Mn |
| 4 | Illumina | 31.39 Bn | 30.22 Bn | 770.00 Mn | 24.00 Mn |
| 5 | Revvity | 13.71 Bn | 12.69 Bn | 416.87 Mn | 25.79 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2.12 Mn |
| 7 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 12.10 Mn |
| 8 | Repligen | 9.47 Bn | 8.45 Bn | 110.04 Mn | 5.66 Mn |
| 9 | 10x Genomics | 8.64 Bn | 8.09 Bn | 112.50 Mn | - |
| 10 | Cytek Biosciences | 600.70 Mn | 526.85 Mn | 28.34 Mn | 281,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 281,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | -725,000.00 |
| Sep 30, 2025 | 494,000.00 |
| Jun 30, 2025 | 414,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | -5.93 Mn |
| Sep 30, 2024 | 119,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 394,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Mar 31, 2023 | 673,000.00 |
| Dec 31, 2022 | 687,000.00 |
| Sep 30, 2022 | 649,000.00 |
| Jun 30, 2022 | 647,000.00 |
| Mar 31, 2022 | 590,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 441,000.00 |